Tumor-targeted niosome as novel carrier for intravenous administration of tocotrienol
2017-01-19
aMalaysian Palm Oil Board,Bandar Baru Bangi,Selangor 43000,Malaysia
bInternational Medical University,Bukit Jalil,Kuala Lumpur 57000,Malaysia
Tumor-targeted niosome as novel carrier for intravenous administration of tocotrienol
Ju-Yen Fua,*,Doryn MeamYee Tana,b,Hui Meng Erb,Yu Sui Chenb, Kalanithi Nesaretnama
aMalaysian Palm Oil Board,Bandar Baru Bangi,Selangor 43000,Malaysia
bInternational Medical University,Bukit Jalil,Kuala Lumpur 57000,Malaysia
A R T I C L E I N F O
Article history:
Available online 25 November 2015
Tocotrienol
Niosome
Tumour-targeted
Breast cancer
Tocotrienol(T3),the unsaturated form of vitamin E,has gained global attention due to its potent anticancer effects against a wide range of cancers.Found abundantly in palm oil[1],T3 was reported to exhibit their anti-cancer properties via various pathways including anti-proliferative,anti-angiogenesis,antiinfammatory,apoptosis and improvement of immunological function[2].However,the lack of tumor specifcity and rapid body clearance have restricted the clinical applications of T3 [3].Nanotechnology offers an alternative approach to novel formulation of tocotrienols as the sub-micron sized niosomes are able to enhance both pharmacokinetic and surface properties of tocotrienol.In this study,transferrin will be investigated as the targeting protein able to recognize the overexpressed transferrin receptors on breast cancer cells.The main objectives of this study are to develop a tumor-targeted nanocarrierbased delivery system for intravenous injection of T3,and evaluate the therapeutic effcacy in human breast cancer cells and murine xenograft tumor models.
Using flm hydration method,spherical niosomes with size less than 200 nm were synthesized.The average encapsulation effciency,drug loading and transferrin-conjugation effciency were 28.0%,5.8%and 13.1%,respectively.The encapsulation ofT3 in niosomes signifcantly improves the in vitro performance of T3,with at least 2-fold enhancement in cytotoxicity effect and 2.5-fold increment in T3 uptake in human breast cancer cells.In animal model,breast cancer cells were subcutaneously implanted to female BALB/c nude mice.Treatment with tumor-targeted niosomes encapsulatedT3 showed reduced tumor volume of 3 times smaller than those injected with freeT3.Note worthily,no sign of adverse effect and signifcant weight loss were observed in all treatment groups. The results were summarized in Fig.1.

Fig.1–Transmission electron micrograph of T3 in tumor targeted niosomes(A)and tumor volume at day 20 in mice bearing breast cancer tumors treated with tumor-targeted T3 niosomes(green),non-targeted T3 niosomes(blue),free T3 (red)and untreated group(black).*Indicates signifcant difference between groups(p<0.05).
In current work,we demonstrated that the encapsulation of T3 in tumor-targeted niosomes resulted in enhanced cytotoxicity andT3 uptake in human breast cancer cells.Meanwhile, signifcant lower rate of tumor growth and tumor volume was observed in tumor-bearing mice treated with tumor-targeted niosomes encapsulating T3.This study exploits the therapeutic potential of T3 cancer therapy for the widespread benefts of patients suffering from cancers.
Acknowledgment
This work was supported by Malaysian Palm Oil Board(MPOB) and International Medical University(IMU).
R E F E R E N C E S
[1]Choo YM,Nesaretnam K.Research advancement in palm oil nutrition.Eur J Lipid Sci Technol 2014;116(10):1301–1313.
[2]Nesaretnam K.Multitargeted therapy of cancer by tocotrienols.Cancer Lett 2008;269(2):388–395.
[3]Fu JY,Che HL,Tan DMY,et al.Bioavailability of tocotrienols: evidence in human studies.Nutr Metab 2014;11(1):5.
*E-mail addresses:fujuyen@mpob.gov.my;fujuyen@gmail.com.
Peer review under responsibility of Shenyang Pharmaceutical University.
http://dx.doi.org/10.1016/j.ajps.2015.10.062
1818-0876/©2016 The Authors.Production and hosting by Elsevier B.V.on behalf of Shenyang Pharmaceutical University.This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/4.0/).
杂志排行
Asian Journal of Pharmacentical Sciences的其它文章
- Determination of the antidepressant effect of mirtazapine augmented with caffeine using Swiss-albino mice
- Photosafety testing of dermally-applied chemicals based on photochemical and cassette-dosing pharmacokinetic data
- Biopharmaceutics classifcation system(BCS)-based biowaiver for immediate release solid oral dosage forms of moxifoxacin hydrochloride (Moxifox GPO)manufactured by the Government Pharmaceutical Organization(GPO)
- Bioequivalence study of abacavir/lamivudine (600/300-mg)tablets in healthy Thai volunteers under fasting conditions
- Evaluation of cytotoxic and infammatory properties of clove oil microemulsion in mice
- Analytical method development of pregabalin and related substances in extended release tablets containing polyethylene oxide
